AP1637A
Celecoxib compositions.
Abstract
Pharmaceutical compositions are provided comprising one or more orally deliverable dose units, each comprising particulate celecoxib in an amount of about 10 mg to 1000 mg in intimate mixture with one or more pharmaceutically acceptable excipients. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| EP0863134A1 | Cites | European Patent Office (EPO) | Search report |
| US5466823A | Cites | United States of America | Search report |
| US5760068A | Cites | United States of America | Search report |
86 members in 49 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 11033398 | United States of America | P | |
| 11033398 | United States of America | P | |
| 9928411 | United States of America | W | |
| 9928411 | United States of America | W | |
| 60110333 | – | – | – |
| PCTUS9928411 | – | – | – |
| US19980110333P | – | – | – |
| WO1999US28411 | – | – | – |
Members86
| Document | Office | Kind | |
|---|---|---|---|
| CA2319201A1 | Canada | A1 | |
| WO0032189A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1838100A | Australia | A | |
| IS5555A | Iceland | A | |
| NO20003815D0 | Norway | D0 | |
| UY26025A1 | Uruguay | A1 | |
| HN1999000210A | Honduras | A | |
| HRP20000434A2 | Croatia | A2 | |
| NO20003815L | Norway | L | |
| PA8486001A1 | Panama | A1 | |
| AP2000001874A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| EP1049467A1 | European Patent Office (EPO) | A1 | |
| PE20001349A1 | Peru | A1 | |
| BR9908030A | Brazil | A | |
| ZA200002722B | South Africa | B | |
| TR2000002207T1 | Türkiye | T1 | |
| TR200002207T1 | Türkiye | T1 | |
| BG104680A | Bulgaria | A | |
| SK11062000A3 | Slovakia | A3 | |
| CN1288378A | China | A | |
| PL341372A1 | Poland | A1 | |
| EA200000718A1 | Eurasian Patent Organization (EAPO) | A1 | |
| KR20010040484A | Republic of Korea | A | |
| IL136532A0 | Israel | A0 | |
| IL136532D0 | Israel | D0 | |
| EE200000437A | Estonia | A | |
| EP1049467A4 | European Patent Office (EPO) | A4 | |
| UY25826A1 | Uruguay | A1 | |
| GT199900203A | Guatemala | A | |
| HK1035144A | Hong Kong, China | A | |
| HK1035144A1 | Hong Kong, China | A1 | |
| AR020015A1 | Argentina | A1 | |
| HU0100867A2 | Hungary | A2 | |
| HUP0100867A2 | Hungary | A2 | |
| HU0100867A3 | Hungary | A3 | |
| HUP0100867A3 | Hungary | A3 | |
| AU748851B2 | Australia | B2 | |
| NZ505762A | New Zealand | A | |
| JP2002531403A | Japan | A | |
| GEP20022784B | Georgia | B | |
| EP1049467B1 | European Patent Office (EPO) | B1 | |
| AT225650T | Austria | T | |
| ATE225650T1 | Austria | T1 | |
| DE69903404D1 | Germany | D1 | |
| IL136532A | Israel | A | |
| DK1049467T3 | Denmark | T3 | |
| PT1049467E | Portugal | E | |
| ES2185412T3 | Spain | T3 | |
| EA003363B1 | Eurasian Patent Organization (EAPO) | B1 | |
| SI1049467T1 | Slovenia | T1 | |
| SK283510B6 | Slovakia | B6 | |
| DE69903404T2 | Germany | T2 | |
| UA58576C2 | Ukraine | C2 | |
| TW579295B | Taiwan Province of China | B | |
| CR6210A | Costa Rica | A | |
| CN1154490C | China | C | |
| YU48600A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| KR20040065307A | Republic of Korea | A | |
| JP3563036B2 | Japan | B2 | |
| OA11616A | African Intellectual Property Organization (OAPI) | A | |
| CN1537531A | China | A | |
| MA26709A1 | Morocco | A1 | |
| HK1069541A | Hong Kong, China | A | |
| HK1069541A1 | Hong Kong, China | A1 | |
| GC0000114A | Patent Office of the Cooperation Council for the Arab States of the Gulf (GCC Patent Office) | A | |
| KR100501034B1 | Republic of Korea | B1 | |
| TNSN99223A1 | Tunisia | A1 | |
| CU20000176A7 | Cuba | A7 | |
| US2005267189A1 | United States of America | A1 | |
| CA2319201C | Canada | C | |
| AP1637AThis record | African Regional Intellectual Property Organization (ARIPO) | A | |
| BG64938B1 | Bulgaria | B1 | |
| SA1603B1 | Saudi Arabia | B1 | |
| SA99191255B1 | Saudi Arabia | B1 | |
| CN1299683C | China | C | |
| EE04834B1 | Estonia | B1 | |
| CR9842A | Costa Rica | A | |
| US2008167362A1 | United States of America | A1 | |
| PL200957B1 | Poland | B1 | |
| RS50158B | Serbia | B | |
| HRP20000434B1 | Croatia | B1 | |
| NO329912B1 | Norway | B1 | |
| ME00416B | Montenegro | B | |
| US2012171284A1 | United States of America | A1 | |
| US2015011514A1 | United States of America | A1 | |
| US9750756B2 | United States of America | B2 |
Numbers
- Publication
- AP 1637
- Publication, DOCDB
- 1637
- Publication, EPODOC
- AP1637
- Application
- 2000001874
- Application, DOCDB
- 2000001874
- Application, EPODOC
- AP19200001874
Titles
- English
- Celecoxib compositions.
Classification
- CPC, 49
- A61K9/2013
- A61K31/415
- A61K31/635
- A61K9/2018
- A61K9/2027
- A61K9/2054
- A61K9/4858
- A61K9/4866
- A61P1/00
- A61P1/04
- A61P1/16
- A61P11/00
- A61P11/06
- A61P13/12
- A61P15/00
- A61P17/00
- A61P17/02
- A61P17/04
- A61P17/06
- A61P17/10
- A61P17/16
- A61P19/02
- A61P19/04
- A61P19/08
- A61P19/10
- A61P21/04
- A61P25/00
- A61P25/04
- A61P25/06
- A61P25/28
- A61P27/02
- A61P27/06
- A61P27/14
- A61P29/00
- A61P31/18
- A61P35/00
- A61P37/00
- A61P37/06
- A61P37/08
- A61P43/00
- A61P7/04
- A61P7/06
- A61P9/00
- A61P9/10
- A61P3/10
- A61K9/1694
- A61K9/0053
- A61K9/2095
- A61K45/06
- IPC, 33
- A61K9 14
- A61K
- A61K9 20
- A61K9 48
- A61K31 135
- A61K31 167
- A61K31 415
- A61K31 451
- A61K31 485
- A61K31 55
- A61K31 7056
- A61P
- A61P1 04
- A61P1 16
- A61P3 10
- A61P7 06
- A61P9 10
- A61P11 06
- A61P17 02
- A61P17 04
- A61P17 06
- A61P19 02
- A61P19 08
- A61P19 10
- A61P21 04
- A61P25 04
- A61P25 28
- A61P27 02
- A61P29 00
- A61P31 18
- A61P35 00
- A61P37 08
- B02C13 22